(Q44417153)

2 December 2017

title

Vaccination of patients with cutaneous T-cell lymphoma using intranodal injection of autologous tumor-lysate-pulsed dendritic cells (English)

1 reference

2 December 2017

Vaccination of patients with cutaneous T-cell lymphoma using intranodal injection of autologous tumor-lysate–pulsed dendritic cells (English)

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-08-2455

27 December 2023

1 reference

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-08-2455

27 December 2023

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-08-2455

27 December 2023

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-08-2455

27 December 2023

author name string

Tanja Maier

1

1 reference

2 December 2017

Adrian Tun-Kyi

2

1 reference

2 December 2017

Anatoli Tassis

3

1 reference

2 December 2017

Karl-Peter Jungius

4

1 reference

2 December 2017

Günter Burg

5

1 reference

2 December 2017

Reinhard Dummer

6

1 reference

2 December 2017

Frank O. Nestle

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714511

27 December 2023

language of work or name

English

0 references

publication date

24 April 2003

1 reference

2 December 2017

1 reference

2 December 2017

volume

102

1 reference

2 December 2017

issue

7

1 reference

2 December 2017

page(s)

2338-2344

1 reference

Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants

2 December 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-08-2455

Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma

27 December 2023

10

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-08-2455

Mimotopes for tumor-specific T lymphocytes in human cancer determined with combinatorial peptide libraries

27 December 2023

11

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-08-2455

Induction of human tumor-loaded dendritic cells

27 December 2023

13

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-08-2455

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

27 December 2023

15

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-08-2455

Dendritic cells: On the move from bench to bedside

27 December 2023

16

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-08-2455

Tumor burden index as a prognostic tool for cutaneous T-cell lymphoma: a new concept

27 December 2023

17

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-08-2455

Reporting results of cancer treatment

27 December 2023

18

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-08-2455

Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions

27 December 2023

19

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-08-2455

A realistic approach to the sensitivity of PCR-DGGE and its application as a sensitive tool for the detection of clonality in cutaneous T-cell proliferations

27 December 2023

21

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-08-2455

Novel methods to monitor antigen-specific cytotoxic T-cell responses in cancer immunotherapy

27 December 2023

22

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-08-2455

Expression of cancer/testis antigens in cutaneous T cell lymphomas

27 December 2023

25

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-08-2455

Serological detection of cutaneous T-cell lymphoma-associated antigens

27 December 2023

26

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-08-2455

Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythrodermic (T4) mycosis fungoides

27 December 2023

27

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-08-2455

An oncologist's approach to therapy for cutaneous T-cell lymphoma

27 December 2023

29

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-08-2455

Treatment of cutaneous T-cell lymphoma from a dermatologist's perspective.

27 December 2023

30

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-08-2455

Pentostatin therapy of T-cell lymphomas with cutaneous manifestations

27 December 2023

31

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-08-2455

Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results

27 December 2023

32

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-08-2455

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

27 December 2023

34

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-08-2455

Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients

27 December 2023

35

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-08-2455

Idiotypic protein-pulsed dendritic cell vaccination in multiple myeloma

27 December 2023

37

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-08-2455

Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects

27 December 2023

38

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-08-2455

Generation of anti-idiotype immune responses following vaccination with idiotype-protein pulsed dendritic cells in myeloma

27 December 2023

39

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-08-2455

27 December 2023

Identifiers

1 reference

2 December 2017

1 reference